why choose us

First received: February 06, 2023

Clinical Trial: Phase 3 Efficacy Study of LNZ101 for the Treatment of Presbyopia

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Presbyopia

Study Type: INTERVENTIONAL


Official Title: A Multi-Center, Double-Masked Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia

Brief Summary: Phase 3 Efficacy Study to evaluate the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia

Read more